I actually think Katie Moore had a good point given the prophylactic surgeries done for BRCA carriers and thinking about studies in women with early high grade cancers related to BRCA. In that vein I am not sure where women with  STIC lesions in study design?

Non high grade histologies I agree are a mixed bag and therefore require an individual approach to address  guided by histology, incidence and potentially molecular characteristics